Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
This study has been withdrawn prior to enrollment.
( No accrual )
Study NCT00110006
Information provided by Case Comprehensive Cancer Center
First Received on May 3, 2005.
Last Updated on June 10, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
